| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2004PNAS..10110762D |
| P356 | DOI | 10.1073/PNAS.0403962101 |
| P932 | PMC publication ID | 490008 |
| P698 | PubMed publication ID | 15247415 |
| P5875 | ResearchGate publication ID | 8462663 |
| P50 | author | Charles Cantor | Q5076088 |
| Pimlak Charoenkwan | Q50997911 | ||
| Tze Kin Lau | Q51980546 | ||
| David H K Chui | Q66829380 | ||
| P2093 | author name string | Chunming Ding | |
| Edmond S K Ma | |||
| Can Liao | |||
| Rossa W K Chiu | |||
| Y M Dennis Lo | |||
| Xiangmin Xu | |||
| Chanane Wanapirak | |||
| Torpong Sanguansermsri | |||
| Hai-Yang Law | |||
| Amy Y Y Chan | |||
| Tse N Leung | |||
| Li C Chan | |||
| Ivy S L Ng | |||
| Mary Anne Tan Jin Ai | |||
| P2860 | cites work | Prenatal detection of fetal hemoglobin E gene from maternal plasma | Q73398751 |
| Prenatal diagnosis of beta-thalassemia major by high-performance liquid chromatography analysis of hemoglobins in fetal blood samples | Q73744800 | ||
| Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma | Q74403995 | ||
| Accuracy of fetal gender determination by analysis of DNA in maternal plasma | Q74542315 | ||
| Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients | Q74716262 | ||
| Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis | Q75424535 | ||
| First-trimester fetal sex determination in maternal serum using real-time PCR | Q77359516 | ||
| Microchimerism: expanding new horizon in human health or incidental remnant of pregnancy? | Q77385792 | ||
| Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia | Q77945374 | ||
| Prenatal exclusion of recessively inherited disorders: should maternal plasma analysis precede invasive techniques? | Q78014573 | ||
| Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study | Q78014625 | ||
| Real time quantitative PCR | Q29616373 | ||
| The thalassaemias | Q30499105 | ||
| Chip-based genotyping by mass spectrometry | Q30761976 | ||
| A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS | Q30892828 | ||
| A review of studies on the detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer | Q33922788 | ||
| Prenatal determination of fetal blood group status. | Q34000357 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Prenatal sex determination by DNA amplification from maternal peripheral blood | Q34465871 | ||
| Application of fetal DNA in maternal plasma for noninvasive prenatal diagnosis | Q34606950 | ||
| Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies? | Q35010397 | ||
| Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed | Q35043252 | ||
| Direct molecular haplotyping of long-range genomic DNA with M1-PCR | Q35145745 | ||
| Biological implications of bi-directional fetomaternal cell traffic: a summary of a National Institute of Child Health and Human Development-sponsored conference. | Q35589383 | ||
| Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service | Q40626763 | ||
| K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer | Q40900133 | ||
| Two-way cell traffic between mother and fetus: biologic and clinical implications. | Q44133343 | ||
| Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR. | Q45289004 | ||
| Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma | Q45750458 | ||
| Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma | Q46353232 | ||
| Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy | Q47274075 | ||
| Cell-free fetal DNA in the cerebrospinal fluid of women during the peripartum period | Q47670314 | ||
| Maternal plasma fetal DNA as a marker for preterm labour. | Q50851221 | ||
| Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. | Q53407197 | ||
| Clinical applications of cell-free fetal DNA from maternal plasma. | Q54735498 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia | Q57671390 | ||
| Prenatal exclusion of β thalassaemia major by examination of maternal plasma | Q58029823 | ||
| Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma | Q63315257 | ||
| Prenatal sex determination | Q68084743 | ||
| Alpha and beta thalassaemia among Chinese children in Guangxi Province, P.R. China: molecular and haematological characterization | Q71625606 | ||
| Beta-thalassemia mutations in Singapore--a strategy for prenatal diagnosis | Q72720037 | ||
| Detection of minority nucleic acid populations by PCR | Q72817463 | ||
| Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21 | Q73045748 | ||
| Prenatal DNA diagnosis of a single-gene disorder from maternal plasma | Q73074402 | ||
| Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses | Q73093957 | ||
| Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong -- implications for population screening | Q73254798 | ||
| P433 | issue | 29 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 10762-10767 | |
| P577 | publication date | 2004-07-09 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis | |
| P478 | volume | 101 |
| Q37155440 | 10. Circulating Nucleic Acids as Diagnostic Tool |
| Q92620044 | A Cell-free DNA Barcode-Enabled Single-Molecule Test for Noninvasive Prenatal Diagnosis of Monogenic Disorders: Application to β-Thalassemia |
| Q45345399 | A new genotyping method for detecting low abundance single nucleotide mutations based on gap ligase chain reaction and quantitative PCR assay |
| Q33221593 | Alpha-thalassaemia and population health in Southeast Asia. |
| Q90724412 | Analysis of fetal DNA in maternal plasma with markers designed for forensic DNA mixture resolution |
| Q81507580 | Application of maternal plasma DNA analysis for noninvasive prenatal diagnosis of Hb E-beta-thalassemia |
| Q37801660 | Application of proteomics to prenatal screening and diagnosis for aneuploidies. |
| Q52883296 | COLD-PCR and microarray: two independent highly sensitive approaches allowing the identification of fetal paternally inherited mutations in maternal plasma. |
| Q38371846 | Cell-free Fetal Nucleic Acid Identifier Markers in Maternal Circulation |
| Q28241617 | Cell-free fetal DNA in maternal plasma: an important advance to link fetal genetics to obstetric ultrasound |
| Q35434562 | Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation |
| Q39778751 | Cell-free fetal nucleic acids as prenatal biomarkers |
| Q37690454 | Circulating nucleic acids in cancer and pregnancy |
| Q36610034 | Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers |
| Q33856619 | Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells |
| Q53289361 | Detection of paternally inherited fetal point mutations for β-thalassemia in maternal plasma using simple fetal DNA enrichment protocol with or without whole genome amplification: an accuracy assessment. |
| Q54443778 | Development of a PCR/LDR/capillary electrophoresis assay with potential for the detection of a beta-thalassemia fetal mutation in maternal plasma. |
| Q38358449 | Development of new substrates for high-sensitive genotyping of minority mutated alleles |
| Q38167823 | Diagnosis and prevention of thalassemia |
| Q58008255 | Different Approaches for Noninvasive Prenatal Diagnosis of Genetic Diseases Based on PNA-Mediated Enriched PCR |
| Q34239768 | Differential DNA methylation as a tool for noninvasive prenatal diagnosis (NIPD) of X chromosome aneuploidies |
| Q34461027 | Efficient detection of Mediterranean β-thalassemia mutations by multiplex single-nucleotide primer extension |
| Q28082499 | Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer |
| Q34558118 | Epigenetic approaches for the detection of fetal DNA in maternal plasma |
| Q98475414 | Evaluation of Beta -Thalassemia in the Fetus through cffDNA with Multiple Polymorphisms as a Haplotype in the Beta-Globin Gene |
| Q56836344 | Fetal DNA detection in maternal plasma throughout gestation |
| Q38002921 | Fetal DNA in maternal plasma: a noninvasive tool for prenatal diagnosis of beta-thalassemia. |
| Q36654711 | Fetal DNA in maternal plasma: progress through epigenetics |
| Q59001540 | Fetal Nucleic Acids in Maternal Circulation: A Genetic Resource for Noninvasive Prenatal Diagnosis |
| Q33257556 | Genotyping fetal paternally inherited SNPs by MALDI-TOF MS using cell-free fetal DNA in maternal plasma: influence of size fractionation |
| Q58008242 | High-sensitive microarray substrates specifically designed to improve sensitivity for the identification of fetal paternally inherited sequences in maternal plasma |
| Q33737845 | MALDI-TOF MS in Prenatal Genomics |
| Q33263722 | MALDI-TOF mass spectrometry for quantitative, specific, and sensitive analysis of DNA and RNA. |
| Q35099257 | Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluids |
| Q36623385 | Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein |
| Q43951172 | No maternally inherited diabetes and deafness mutations in a sample of 193 Tasmanian diabetics with glaucoma. |
| Q85181748 | Non-invasive Prenatal Diagnosis |
| Q36431820 | Non-invasive antenatal RHD typing |
| Q37809306 | Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age |
| Q36424760 | Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications |
| Q38770436 | Non-invasive prenatal diagnosis of β-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis. |
| Q36117921 | Non-invasive prenatal diagnosis using cell-free fetal nucleic acids in maternal plasma: Progress overview beyond predictive and personalized diagnosis |
| Q35885009 | Non-invasive prenatal diagnosis using fetal DNA in maternal plasma: a preliminary study for identification of paternally-inherited alleles using single nucleotide polymorphisms |
| Q54184929 | Non-invasive prenatal diagnostic testing for β-thalassaemia using cell-free fetal DNA and next generation sequencing. |
| Q38088416 | Non-invasive prenatal diagnostics using next generation sequencing: technical, legal and social challenges |
| Q50051267 | Non-invasive prenatal testing for fetal inheritance of maternal β-thalassaemia mutations using targeted sequencing and relative mutation dosage: a feasibility study |
| Q37809342 | Noninvasive Approaches to Prenatal Diagnosis of Hemoglobinopathies Using Fetal DNA in Maternal Plasma |
| Q44912114 | Noninvasive prenatal diagnosis experience in the Çukurova Region of Southern Turkey: detecting paternal mutations of sickle cell anemia and β-thalassemia in cell-free fetal DNA using high-resolution melting analysis |
| Q37000915 | Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma |
| Q38002933 | Noninvasive prenatal diagnosis of monogenic disorders |
| Q37705437 | Noninvasive prenatal diagnosis using ccffDNA in maternal blood: state of the art. |
| Q39850180 | Prenatal diagnosis of fetal aneuploidies: post-genomic developments |
| Q36673937 | Prenatal diagnosis: progress through plasma nucleic acids |
| Q37322448 | Prenatal diagnosis: update on invasive versus noninvasive fetal diagnostic testing from maternal blood |
| Q54088983 | Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis. |
| Q33237610 | Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping |
| Q33274418 | Recent developments in the detection of fetal single gene differences in maternal plasma and the role of size fractionation |
| Q34042854 | Reliable detection of paternal SNPs within deletion breakpoints for non-invasive prenatal exclusion of homozygous α-thalassemia in maternal plasma |
| Q35069908 | Restriction enzyme-mediated enhanced detection of circulating cell-free fetal DNA in maternal plasma |
| Q33450163 | Simple, efficient, and cost-effective multiplex genotyping with matrix assisted laser desorption/ionization time-of-flight mass spectrometry of hemoglobin beta gene mutations |
| Q36095650 | The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer. |
| Q26995586 | Tracking fetal development through molecular analysis of maternal biofluids |
| Q51039797 | Variability of ffDNA in maternal plasma does not prevent correct classification of trisomy 21 using MeDIP-qPCR methodology. |
Search more.